Asthma ppt

23

description

asthma,causes ,types,pathophysiology,clinicalmanifestations,,management

Transcript of Asthma ppt

Page 1: Asthma ppt
Page 2: Asthma ppt

INTRODUCTION:

Asthma is a lower respiratory tract disease;it is an pulmonary obstructive disease.It is also called as “REACTIVE AIRWAY DISEASE

Page 3: Asthma ppt

DEFINITION:

Asthma  is a common chronicinflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. Common symptoms include wheezing, coughing, chest tightness, and shortness of breath

Page 4: Asthma ppt

INCIDENCE:

It can occur in any age and in any sex26 million are diagnosed with asthma

every year10.6 million people are affectedWomens are increased risk of death

compare to menIn India 4000-6000 are dying every year

with asthma

Page 5: Asthma ppt
Page 6: Asthma ppt

TYPES:

Page 7: Asthma ppt

ETIOLOGY:

Idiopathic

Page 8: Asthma ppt

CAUSES:

Page 9: Asthma ppt

RISK FACTORS:

HereditaryAllergensAirpollutantsUpper respiratory tract infectionsDrug over dosageOccupational exposuresEnvironmental factorsPsychological factors

Page 10: Asthma ppt

PATHOPHYSIOLOGY:

Page 11: Asthma ppt

CLINICAL MANIFESTATIONS:

WheezingCoughChest tightnessDysponeHypoxiaNasal flaringSputum is thick and tenaciousDecreased or absence of breath sounds

called “SILENT CHEST”

Page 12: Asthma ppt

SYMPTOMS:

Page 13: Asthma ppt

ASSESSMENT AND DIAGNOSTIC STUDIES:History collectionPhysical examinationPulse oximetryPulmonary function testArterial blood gasComplete blood countChest x-ray

Page 14: Asthma ppt

MANAGEMENT:

Medications: Bronchodilators:

-long acting beta adrenagic blockers:

eg:salmeterol,formeterol,theophylline Anti-inflammatory drugs:

-corticosteriods:

eg:flunisolides,beclamethasone,cromolyn

-Mast cell stabilizers:

eg:montelukast,zileuton DRY POWDER INHALERS

Page 15: Asthma ppt

CORTICOSTEROIDS ARE MOST EFFECTIVE

Page 16: Asthma ppt

DELIVERY METHODS:

Medications are typically provided as metered-dose inhalers (MDIs) in combination with an asthma spacer or as a dry powder inhaler. The spacer is a plastic cylinder that mixes the medication with air, making it easier to receive a full dose of the drug. A nebulizer may also be used.

Page 17: Asthma ppt

ADVERSE EFFECTS:

Long-term use of inhaled corticosteroids at conventional doses carries a minor risk of adverse effects.Risks include the development of cataracts and a mild regression in stature.

Page 18: Asthma ppt

OTHER METHODS:

When asthma is unresponsive to usual medications, other options are available for both emergency management and prevention of flareups. For emergency management other options include:

Oxygen to alleviate hypoxia if saturations fall below 92%.

Oral corticosteroid are recommended with five days of prednisone being the same 2 days of dexamethasone.

Page 19: Asthma ppt

Magnesium sulfate intravenous treatment has been shown to provide a bronchodilating effect when used in addition to other treatment in severe acute asthma attacks.

Heliox, a mixture of helium and oxygen, may also be considered in severe unresponsive cases

Page 20: Asthma ppt

COMORBIDITES:

Page 21: Asthma ppt

NURSING MANAGEMENT:

Check vitalsigns at regular intervals. Monitor allergic symptoms. Administer medication, note action of

medications. Avoid exposure to pollution environment. Deep breathing exercises. Health education.

Page 22: Asthma ppt

NURSING DIAGNOSIS:

Ineffective airway cleareance related to bronchospasm.

Impaired breathing pattern related to excessive mucus secretion.

Sleep pattern disturbance related to cough and dysponea.

Anxiety related to difficulty in breathing.Knowledge deficit related to treatment

regimen.

Page 23: Asthma ppt

yamini